1. Evidence-Based Medicine and the Selection of Lipid-Lowering Therapy in Type 2 Diabetes

   • Carlos A. Aguilar-Salinas
   • Roopa Mehta
   • Rita A. Gomez-Diaz

   Invited Commentary 24 March 2012 Pages: 221 - 223

2. Type 1 Diabetes Mellitus in India

   • Eesh Bhatia

   Invited Commentary 28 March 2012 Pages: 224 - 226

3. The Role of Combination Therapy in Type 2 Diabetes in the Post-ACCORD Era

   • Louis Kuritzky

   Invited Commentary 17 April 2012 Pages: 227 - 229

4. Efficacy and Safety of SGLT2 Inhibitors in the Treatment of Type 2 Diabetes Mellitus

   • Muhammad A. Abdul-Ghani
   • Luke Norton
   • Ralph A. DeFronzo

   Pharmacologic Treatment of Type 2 Diabetes and Obesity (D Wexler, Section Editor) 15 April 2012 Pages: 230 - 238

   

5. Treatment of Type 2 Diabetes in the Elderly

   • Medha N. Munshi
   • Megumi Maguchi
   • Alissa R. Segal

   Pharmacologic Treatment of Type 2 Diabetes and Obesity (D Wexler, Section Editor) 10 April 2012 Pages: 239 - 245

   

6. A Review and Critical Analysis of Professional Societies’ Guidelines for Pharmacologic Management of Type 2 Diabetes Mellitus

   • Robert A. Vigersky

   Pharmacologic Treatment of Type 2 Diabetes and Obesity (D Wexler, Section Editor) 16 March 2012 Pages: 246 - 254

7. Glycemic Control and Cardiovascular Disease: What’s a Doctor to Do?

   • Preeti Kishore
   • Sharon H. Kim
   • Jill P. Crandall

   Cardiovascular Prevention in Diabetes (T Orchard, Section Editor) 01 April 2012 Pages: 255 - 264

8. Metformin Use Among Individuals at Risk for Type 2 Diabetes

   • Lewis H. Kuller

   Cardiovascular Prevention in Diabetes (T Orchard, Section Editor) 08 March 2012 Pages: 265 - 273

9. Is It Time to Screen for the Haptoglobin Genotype to Assess the Cardiovascular Risk Profile and Vitamin E Therapy Responsiveness in Patients with Diabetes?

   • Moshe Vardi
   • Andrew P. Levy

   Cardiovascular Prevention in Diabetes (T Orchard, Section Editor) 18 March 2012 Pages: 274 - 279

10. The Distinctive Nature of Atherosclerotic Vascular Disease in Diabetes: Pathophysiological and Morphological Insights

    • Rishi Puri
    • Yu Kataoka
    • Stephen J. Nicholls

    Management of Macrovascular Disease in Diabetes (S Inzucchi and R Goldberg, Section Editors) 11 April 2012 Pages: 280 - 285

11. Diagnosis of Coronary Artery Disease in Persons with Diabetes Mellitus

    • Nima Alipour
    • Nathan D. Wong
    • Shaista Malik

    Management of Macrovascular Disease in Diabetes (S Inzucchi and R Goldberg, Section Editors) 13 April 2012 Pages: 286 - 293

12. Diabetes Mellitus and Acute Coronary Syndrome: Lessons From Randomized Clinical Trials

    • Sanjum S. Sethi
    • Elias G. Akl
    • Michael E. Farkouh

    Management of Macrovascular Disease in Diabetes (S Inzucchi and R Goldberg, Section Editors) 22 April 2012 Pages: 294 - 304

    

13. Update on Diabetic Cardiomyopathy: Inches Forward, Miles to Go

    • Maggie N. Tillquist
    • Thomas M. Maddox

    Management of Macrovascular Disease in Diabetes (S Inzucchi and R Goldberg, Section Editors) 15 April 2012 Pages: 305 - 313

    

14. The Diagnosis and Management of Cerebrovascular Disease in Diabetes

    • Michael S. Phipps
    • Ania M. Jastreboff
    • Walter N. Kernan

    Management of Macrovascular Disease in Diabetes (S Inzucchi and R Goldberg, Section Editors) 11 April 2012 Pages: 314 - 323